Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer

This is a prospective, multicenter, randomized, open-label clinical trial. It aims to investigate whether intensive transarterial infusion chemotherapy (TAIC) followed by sequential intravenous chemotherapy (IVC) is clinically more effective than IVC alone in the treatment of unresectable colorectal cancer (uCRC).

Trial Details

NCT ID
NCT07333053
Phase
NA
Sponsor
Quanda Liu
Status
RECRUITING
Cancer Type
Colorectal Cancer
Interventions
  • Transarterial infusion chemotherapy (TAIC)
  • Intravenous Chemotherapy（IVC）
Locations (sample)
  • Xicheng, Beijing Municipality, China

Key Eligibility Criteria

  • Inclusion criteria:
  • Age ≥ 18 years old;
  • Histopathologically confirmed CRC adenocarcinoma;
  • Locally advanced CRC confirmed as clinical T4 stage on CT/MRI imaging, with or without synchronous liver metastases;

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Colorectal Cancer Trials on Trialify →